A Risk Management Plan is only useful if it reflects what you know about your product today. Jeyflex develops and maintains Risk Management Plans and risk minimization programs across the full lifecycle, from first draft and submission through to tracking whether your measures are actually working.
Is Your Risk Management Plan Up to Date With Your Product's Safety Profile?
What is a Risk Management Plan (RMP)?
A Risk Management Plan (RMP) is a detailed document that describes the risk management system for a medicinal product. It sets out the identified risks, potential risks, and gaps in knowledge, and describes the measures taken to minimize those risks and the way their effectiveness will be monitored and assessed.
Jeyflex builds RMPs that are practical to run, clear to regulators, and kept in step with your safety data.

How Jeyflex Manages Your Risk Management Plan
We cover the complete RMP lifecycle, following the structure set out in GVP Module V, from the first assessment through to evaluating whether your measures work.
RMP Assessment & Planning
We review your product’s safety data and any existing RMP, confirm what each target market requires, and agree a plan and timeline before any drafting begins.
Safety Specification
We document the identified risks, potential risks, and missing information for your product, so the plan is built on a clear, evidence-based picture of its safety profile.
Pharmacovigilance Plan
We define the routine and additional pharmacovigilance activities, including Post-Authorization Safety Studies (PASS) where needed, that will close the knowledge gaps identified in the specification.
Risk Minimization Plan
We set out the routine measures, such as product labeling and Product Information Leaflets (PILs), and any Additional Risk Minimization Measures (aRMM) needed for specific safety concerns.
Submission & Authority Queries
We prepare the submission for each Health Authority, adapt the plan to local regulatory requirements, and support you through any questions or requests for changes.
Tracking & Effectiveness Evaluation
We track the measures in place, assess whether they are working, and update the RMP when new safety information or evaluation results require it.
Additional Risk Minimization Measures (aRMM)
Where routine measures are not enough to manage a specific safety concern, additional risk minimization measures may be needed. Jeyflex supports the full aRMM process:
Risk management goes beyond documentation. We also incorporate key safety information into PILs, support Post-Authorization Safety Studies, and help deliver educational and support programs for healthcare professionals and patients.
Why Choose Jeyflex for Risk Management Plans?
Our Risk Management Services
A complete set of services to develop, submit, maintain, and evaluate your risk management plans.
What Happens When Your RMP Falls Behind?
An RMP is a living document. When it stops reflecting reality, the gaps tend to surface at the worst moments:
Risk management is not a one-time submission. It has to evolve with your product’s safety data for as long as the product is on the market.
Frequently Asked Questions
An RMP describes the safety profile of a medicinal product and how its risks will be managed. It typically includes a safety specification (identified risks, potential risks, and missing information), a pharmacovigilance plan covering the activities that will address those gaps, and a risk minimization plan describing the measures used to reduce risks and how their effectiveness will be assessed.
An RMP is the risk management document used under EU-style pharmacovigilance rules, which many regulators follow or reference. A Risk Evaluation and Mitigation Strategy (REMS) is the US FDA’s equivalent framework, applied to selected products with serious safety concerns. Which one applies depends on the market where the product is authorized. Jeyflex advises on the right approach for each target market.
An RMP should be updated whenever significant new safety information emerges or when the risk minimization measures change. It is also updated when a regulator requests it, or when your signal management, PSUR, or study results change the safety picture. Jeyflex monitors these triggers so your plan stays aligned with your safety data.
Additional risk minimization measures are interventions beyond routine labeling and product information, used when routine measures are not enough to manage a specific risk. Examples include educational materials for healthcare professionals or patients, and controlled distribution arrangements. They usually need Health Authority approval, and their effectiveness should be tracked. Jeyflex supports design, approval submissions, distribution, and effectiveness assessment.
Yes. We take an existing global RMP and adapt it to the requirements of each African market where the product is registered, including local aRMM and submission formats where an authority expects them. Requirements vary by country, and we advise on what applies in each market you operate in.
Keep Your Risk Management Plan Working for You
Whether you need a new RMP written, an existing plan reviewed and updated, or help designing and tracking additional risk minimization measures, Jeyflex is ready to help.

